ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented at Kidney Week, the annual meeting of the American Society of Nephrology, held from Oct. 23 to 27 in San Diego.
Sree Abhilekha Purohit, M.B.B.S., from the Shadan Institute of Medical Sciences in Hyderabad, India, and colleagues evaluated the global burden of CKD in women in 2,014 countries from 1990 to 2021.
The researchers report that the average annual percentage change in prevalence increased by 2.10 percent, mortality by 3.39 percent, and disability-adjusted life-years by 2.48 percent. The highest incidence rates of CKD due to type 1 diabetes occurred in Eastern Europe (2.07 cases per 100,000 persons), while CKD due to type 2 diabetes was highest in the Middle East and North Africa (43 cases per 100,000 persons). CKD attributable to hypertension (25.18 cases per 100,000 persons) and glomerulonephritis (5.69 cases per 100,000 persons) was notably prevalent in the Middle East and North Africa and Central Latin America, respectively. New CKD was most substantially seen in those aged 70 to 74 years (1.66 million cases in 2021), while the highest mortality rates were observed among those aged 85 to 89 years (92,279 deaths in 2021).
"Type 2 diabetes mellitus was the leading cause of CKD-related deaths among women in 2021, followed by CKD due to hypertension," the authors write. "There is a critical need for increased awareness, education, and comprehensive campaigns aimed at women's health involving public stakeholders and clinicians to address and mitigate these impacts."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
THURSDAY, July 17, 2025 -- Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.